Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Jun 21;30(9):1660–1668. doi: 10.1158/1055-9965.EPI-21-0162

Table 5.

Odds ratios and 95% CIs for the association between duration of genital powder use and ovarian cancer, overall and by race, stratified by histotype

All cases High-grade serous All other histotypes
Duration of usea Controls (%) Cases (%) MVb
OR (95% CI)c
Cases (%) MVb
OR (95% CI)c
Cases (%) MVb
OR (95% CI)c
All participants
No genital use 5403 (69.5) 2374 (71.1) 1.00 1452 (70.4) 1.00 900 (72.1) 1.00
≤20 years 1443 (18.6) 534 (16.0) 1.43 (1.22–1.68) 334 (16.2) 1.42 (1.17–1.71) 198 (15.9) 1.44 (1.16–1.78)
>20 years 924 (11.9) 483 (12.9) 1.28 (1.08–1.51) 277 (13.4) 1.32 (1.09–1.60) 151 (12.1) 1.19 (0.94–1.50)
ptrendd 0.97 0.71 0.58
African Americans
No genital use 756 (67.7) 398 (66.0) 1.00 255 (65.2) 1.00 141 (67.1) 1.00
≤20 years 196 (17.6) 106 (17.6) 1.44 (1.06–1.95) 67 (17.1) 1.53 (1.07–2.18) 39 (18.6) 1.29 (0.83–2.00)
>20 years 164 (14.7) 99 (16.4) 1.06 (0.78–1.44) 69 (17.7) 1.19 (0.84–1.69) 30 (14.3) 0.83 (0.52–1.34)
ptrendd 0.19 0.39 0.28
Whites
No genital use 4647 (69.8) 1976 (72.2) 1.00 1197 (71.6) 1.00 759 (73.1) 1.00
≤20 years 1247 (18.7) 428 (15.6) 1.42 (1.17–1.71) 267 (16.0) 1.35 (1.08–1.69) 159 (15.3) 1.47 (1.15–1.88)
>20 years 760 (11.4) 333 (12.2) 1.40 (1.14–1.72) 208 (12.4) 1.40 (1.11–1.77) 121 (11.7) 1.36 (1.03–1.80)
ptrendd 0.33 0.26 0.83
a

Duration of use variable includes the following study sites: AACES, CCCS, NCOCS, LACOCS, WHI

b

MV=Multivariable

c

Adjusted for age (continuous), education (high school graduate/GED or less, some college, college graduate, graduate/professional school), duration of OC use (months, continuous), family history of breast cancer (no, yes, family history of ovarian cancer (no, yes), tubal ligation (yes, no), full term pregnancies (number of pregnancies ≥ 6 months, continuous), hysterectomy (no, yes), interview year (continuous), BMI (<25.0, 25.0–29.9, 30.0–34.9, ≥35.0), menopausal (premenopausal, postmenopausal), smoking (ever, never), study site (AACES, CCCS, NCOCS, LACOCS, WHI)

d

Determined using category median values